Home

Claire Poll

CIK 1836820 · General Counsel · last filed 2024-02-05

Claire Poll is a General Counsel who has filed 15 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for VRNA, was dated Feb 5, 2024. Across all open-market trades the lifetime net is −$1.5M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

15

Lifetime Open-Market Net

-$1.45M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Verona Pharma plc (VRNA) Delisted General Counsel 2,800,407 $106.91 $299.39M -$1.45M 15 2024-02-05

Recent Filings

15 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-02-05 Verona Pharma plc (VRNA) Delisted Mixed −103,408 -$237.2K EDGAR
2023-11-03 Verona Pharma plc (VRNA) Delisted Mixed −173,904 -$303.3K EDGAR
2023-10-24 Verona Pharma plc (VRNA) Delisted Grant (A) +200,000 $0 EDGAR
2023-08-07 Verona Pharma plc (VRNA) Delisted Mixed −48,472 -$121.9K EDGAR
2023-08-03 Verona Pharma plc (VRNA) Delisted Sell (S) −31,552 -$83.4K EDGAR
2023-05-11 Verona Pharma plc (VRNA) Delisted Exer (M) +8,328 $0 EDGAR
2023-05-03 Verona Pharma plc (VRNA) Delisted Sell (S) −80,376 -$207.0K EDGAR
2023-02-03 Verona Pharma plc (VRNA) Delisted Mixed +26,800 -$394.3K EDGAR
2022-12-27 Verona Pharma plc (VRNA) Delisted Mixed −240,000 -$646.0K EDGAR
2022-09-28 Verona Pharma plc (VRNA) Delisted Grant (A) +800,000 $0 EDGAR
Showing 1–10 of 15
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.